![]() |
|
|
Vol. 60, Issue 3, 528-533, September 2001
)-Epigallocatechin-3-Gallate Blocks
Nuclear Factor-
B Activation by Inhibiting I
B Kinase Activity in
the Intestinal Epithelial Cell Line IEC-6
Graduate Program in Nutritional Sciences (F.Y., S.B., W.J.S.D.V., C.J.M., G.W.V.) and Department of Internal Medicine (W.J.S.D.V.), University of Kentucky and Veterans Administration Medical Center, Lexington, Kentucky; and Departments of Internal Medicine (H.S.O., S.B., C.J.M., G.W.V.) and Pharmacology and Toxicology (S.B., C.J.M.), University of Louisville and Veterans Administration Medical Center, Louisville, Kentucky
| |
Abstract |
|---|
|
|
|---|
The I
B kinase complex (IKK) mediates activation of the
transcription factor nuclear factor-
B (NF-
B). We previously
showed that green tea polyphenols inhibited endotoxin-mediated tumor necrosis factor-
(TNF
) production by blocking NF-
B activation. In this study, we evaluated whether green tea polyphenols inhibit NF-
B by blocking IKK activity. We assessed IKK activity by detecting changes in phosphorylation of an I
B
-glutathione
S-transferase (GST) fusion protein. IEC-6 cells
pretreated with an extract of green tea polyphenols (GrTPs; 0-0.4
mg/ml) had diminished TNF
-induced IKK and NF-
B activity. Of the
various GrTPs, (
)-epigallocatechin-3-gallate (EGCG) was the most
potent inhibitor. We next examined whether EGCG inhibited activated
IKK. In cytosolic extracts of TNF
-stimulated cells, EGCG inhibited
phosphorylation of I
B
-GST (IC50 > 18 µM) consistent with inhibition of IKK activity. Using other polyphenols, we
showed that the gallate group was essential for inhibition, and
antioxidants were ineffective in blocking activated IKK. Importantly, EGCG decreased IKK activity in cytosolic extracts of NIK transiently transfected cells. This latter finding showed that our findings were
not related to nonspecific kinase activity. In conclusion, EGCG is an
effective inhibitor of IKK activity. This may explain, at least in
part, some of the reported anti-inflammatory and anticancer effects of
green tea.
| |
Introduction |
|---|
|
|
|---|
There
is increasing interest in the role of tea (Camellia
sinensis) in maintaining health and treating disease. Although tea consists of several components, research has focused on polyphenols, especially those found in green tea. The green tea polyphenols include
(
)-epicatechin (EC), (
)-epigallocatechin (EGC),
(
)-epicatechin-3-gallate (ECG), and (
)-epigallocatechin-3-gallate
(EGCG). Of these, EGCG generally accounts for greater than 40% of the
total (Hara, 1997
). Green tea polyphenols are potent antioxidants
(Salah et al., 1995
). EGCG usually has the greatest antioxidant
activity, and it is the most widely studied polyphenol for disease
prevention (for review, see Bagchi, 1999
). Many of the putative health
benefits of tea are presumed to be caused by its antioxidant effects.
One benefit may be cancer prevention. Epidemiological studies suggest that regular consumption of tea reduces the risk of cancer (Katiyar and
Mukhtar, 1996
). In support of this contention, tea, or, more specifically, the polyphenol fraction, has been reported to decrease the incidence of carcinogen-induced malignancies in animal models (Stoner and Mukhtar, 1995
). One proposed mechanism of action is the
finding that polyphenols induce apoptosis more readily in cancer cells
than their natural counterparts (Chen et al., 1998
; Yang et al., 1998b
;
Suganuma et al., 1999
; Ahmad et al., 2000
).
Another potential benefit of tea is as an anti-inflammatory agent.
Studies in animal models show that green tea polyphenols decrease
inflammation. We reported that mice fed an extract of green tea
polyphenols had decreased tumor necrosis factor-
(TNF
) production
in response to an injection of lipopolysaccharide (LPS) and prevented
death after administration of an otherwise lethal dose of LPS (Yang et
al., 1998a
). Haqqi et al. (1999)
reported that the ingestion of a green
tea polyphenol extract reduced joint disease in mice with
adjuvant-induced arthritis. We recently reported that green tea
polyphenols reduced disease activity in the autoimmune disease model,
interleukin-2 deficient mice (Varilek et al., 1999
). These studies
suggest that green tea may have benefit in treating inflammatory disorders.
Several studies have focused on potential mechanisms responsible for
the anti-inflammatory and anticancer effects. One potential mechanism
of action is the inhibition of nuclear factor-
B activation. Nuclear
factor-
B is an oxidative stress sensitive transcription factor that
regulates the expression of a variety of genes important in cellular
responses, including inflammation, innate immunity, and growth. We
showed that EGCG decreased LPS-induced TNF
production in the
macrophage cell line RAW264.7 and peritoneal macrophages by blocking
NF-
B activation (Yang et al., 1998a
). Lin and Lin (1997)
reported
that EGCG inhibited LPS-induced inducible nitric-oxide synthase
gene expression in mouse peritoneal macrophages by decreasing the
expression of the transcription factor, NF-
B. Ahmad et al. (2000)
recently showed that green tea polyphenols modulate NF-
B in several
cancer cell lines, rendering them susceptible to apoptosis.
In unstimulated cells, NF-
B predominantly exists as a heterodimer,
composed of p65 and p50 subunits, that resides in the cytoplasm in an
inactive state bound to a member of the I
B family of inhibitory
proteins (Baldwin, 1996
; Barnes and Karin, 1997
). I
B masks the
nuclear localization sequence of NF-
B, sequestering it in the
cytoplasm. NF-
B activity can be induced in most cell types upon
exposure to stimuli including cytokines (TNF
, interleukin-1), endotoxin, and oxidative stress (Baldwin, 1996
). NF-
B activators induce degradation of I
B by the 26S proteasome. This requires the phosphorylation of two serines (Ser-32 and Ser-36 in I
B
) in
the N-terminal regulatory domain of I
B, followed by
polyubiquitination. The liberated NF-
B then translocates to the
nucleus, binds to specific sequences in the promoter region, and
induces gene expression (Karin, 1999
). Several anti-inflammatory
agents, including aspirin and sodium salicylate, inhibit the activity
of IKK (Yin et al., 1998
). Antioxidants such as
pyrrolidinedithiocarbamate (PDTC), N-acetyl cysteine (NAC),
and vitamin E also suppress NF-
B activation (Suzuki and Packer 1993
;
Beauparlant and Hiscott, 1996
). Recently, Pan et al. (2000)
showed that
the black tea derivative theaflavin-3,3'-digallate and EGCG block the
phosphorylation of I
B; however, the study did not determine whether
these polyphenols blocked the activation of IKK or inhibited the
activity of IKK. Both mechanisms would lead to a reduction in I
B phosphorylation.
In this study, we used IEC-6 intestinal cells, because intestinal epithelial cells are the early targets for consumed green tea polyphenols. We identified EGCG as the most potent inhibitor of IKK among green tea polyphenols. Importantly, this function of EGCG appeared to be independent of its antioxidant property. Our data suggest that most anti-inflammatory effects of green tea are mediated by EGCG rather than other polyphenol extracts. Through comparison among structurally similar compounds, we conclude that the gallate group plays a crucial role for inhibiting IKK activates; however, the catechin structure is also required. This information may be used in design of more potent IKK inhibitors in the future.
| |
Experimental Procedures |
|---|
|
|
|---|
Materials.
Extracted green tea polyphenols (GrTP; >95%
polyphenols) were purchased from LKT Laboratories, Inc (St. Paul, MN).
High-performance liquid chromatography analysis of the green tea
extracts revealed the percentage composition of the four polyphenols of
interest: 35% EC, 4% EGC, 15% EGC, and 38% EGCG. Cell culture
supplies were obtained from Invitrogen (Carlsbad, CA).
[
-32P]ATP (6000 mCi/mmol) was obtained from
PerkinElmer Life Science Products (Boston, MA). The fusion
protein (70 kDa) containing the full-length I
B-
of human origin
and glutathione S-transferase (GST), rabbit polyclonal IgG
antibody against GST, and protein-A-agarose were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA). EGCG (>98% pure), ECG (>98%
pure), and remaining chemicals were purchased from Sigma (St. Louis, MO).
Cell Culture. The fetal rat intestinal epithelial cell line, IEC-6 was obtained from the American Type Culture Collection (Manassas, VA). The cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% (v/v) endotoxin-free fetal calf serum, 2 mM glutamine, and 1 × 105 U/liter of penicillin/streptomycin at 37°C in an atmosphere of 10% CO2 and 95% relative humidity. Passage consisted of incubating cells in sterile trypsin/EDTA followed by resuspending the cells in fresh medium. The cells were studied between passages 20 and 35.
Cytosolic and Nuclear Extraction.
Cytosolic and nuclear
extracts were isolated by the method initially described by Dignam et
al. (1983)
with the addition of protease inhibitors (1 µg/l
leupeptin, 1 µg/l pepstatin, and 1 µg/l leucine thiol) to the lysis
and nuclear extraction buffers (Yang et al., 1998a
). IEC-6 cells
(5 × 106/plate) were seeded onto 60-mm
culture plates and cultured to 90% confluence. After various
treatments, the cells were washed twice with ice-cold PBS and incubated
on ice for 15 min with 0.2 ml of ice-cold lysis buffer. The cells were
collected into 1.5-ml polypropylene tubes, incubated on ice for 30 min,
and then underwent centrifugation at 1,200g for 10 min at
4°C. For cytosolic extracts, supernatants were collected and
underwent a second centrifugation at 13,000g for 10 min at
4°C. The resulting supernatants (cytosolic extracts) were stored at
70°C. For nuclear extracts, pellets from the initial centrifugation
were incubated in nuclear extraction buffer on ice for 1 h
followed by centrifugation at 110,000g for 15 min at 4°C.
The supernatants were stored at
70°C. The protein concentration of
the cytosolic and nuclear extracts was measured using the
Dc Protein Assay kit (Bio-Rad Laboratories,
Hercules, CA).
IKK Assay.
I
B kinase activity was assessed by detecting
the phosphorylation of I
B
-GST fusion protein. Ten micrograms of
cytosolic extract and 2.5 µg of I
B
-GST fusion protein were
incubated for 30 min at 37°C in 20 mM HEPES (pH 7.5) containing 20 mM
-glycerophosphate, 10 mM MgCl2, 10 mM
p-nitrophenyl phosphate, 0.1 mM
Na3VO4, 2 mM dithiothreitol, 10 µg/ml aprotinin, 20 µM ATP, 0.1 mM NaCl, 0.4 mM
phenylmethylsulfonyl fluoride, and 15 µCi
-32P-ATP (Regnier et al., 1997
). The reaction
was stopped by adding ten volumes of an immunoprecipitation (IP) buffer
consisting of 0.1 M Tris-HCl (pH = 8.0) with 1% (v/v) Triton
X-100, 1% (w/v) deoxycholate, 0.5% (w/v) SDS, and 2 mM
phenylmethylsulfonyl fluoride. The I
B
-GST proteins were
immunoprecipitated by incubating the samples with a rabbit polyclonal
IgG antibody against GST (1:500) and protein-A-agarose (20 µl)
followed by extensive washes with IP buffer. The phosphorylated
I
B
-GST proteins then were visualized by 5 to 15%
SDS-polyacrylamide gel electrophoresis and autoradiography. Densitometry was performed on the resulting bands using a Personal Densitometer SI (Molecular Dynamics, Sunnyvale, CA) with ImageQuant V1.1 (Molecular Dynamics).
Electrophoretic Mobility Shift Assay (EMSA).
The DNA binding
activity of NF-
B was detected in nuclear protein extracts by an
electrophoretic mobility shift assay (Yang et al., 1998a
).
32P-End-labeled oligonucleotide probes containing
the
B enhancer DNA element (Santa Cruz Biotechnology, Inc.) were
prepared according to protocol (Sambrook et al., 1989
). Incubation of 8 µg of the nuclear extract with the end-labeled probe for 20 min at
room temperature was carried out in the presence of sonicated salmon sperm DNA, which served as a nonspecific competitor. Complexed and
uncomplexed DNA were then resolved by electrophoresis on a 6%
low-ionic-strength nondenaturing polyacrylamide gel and visualized by
autoradiography. To identify the specific subunits of NF-
B, supershift experiments were performed by incubating nuclear extracts with 1 µl of antibodies against p65 or p50 (Santa Cruz Biotechnology, Inc.) for 30 min before adding the end-labeled probe. To confirm the
binding specificity, competition experiments were performed by adding
100-fold of unlabeled NF-
B consensus oligonucleotides as specific competitors.
Cytokine-Induced Neutrophil Chemoattractant (CINC)
Immunoassay.
IEC-6 cells (1 × 105)
were plated onto 24-well cluster plate. At 80% confluence, the cells
were pretreated with various concentrations of EGCG or EGC (0-100
µM) for 2 h followed by stimulation with TNF
(500 U/ml). The
cells were incubated overnight and the supernatants collected at
18 h. The concentrations of CINC in the culture supernatants were
determined by sandwich enzyme-linked immunosorbent assay using the
method described by Wittwer et al. (1993)
. The rabbit polyclonal IgG
antibody against CINC and CINC (standards) were purchased from Peptides
International (Louisville, KY). The goat polyclonal IgG antibody
against CINC was kindly provided by Dr. John Zagorski (Laboratory of
Immunology, National Institute of Dental Research, National Institutes
of Health, Bethesda MD).
NF-
B-Inducing Kinase (NIK) transient transfection.
PRK-Myc-NIK, a full-length NIK expression vector was kindly provided by
Dr. Warner Greene (Gladstone Institute of Virology and Immunology,
University of California) (Lin et al., 1998
). IEC-6 cells (5 × 105) were seeded onto six-well (35 mm diameter)
cluster plates and transfected the following day with 1.2 µg of
pRK-Myc-NIK using the LipofectAMINE PLUS Reagent kit
(Invitrogen) according to the methods provided by the
manufacturer. Control plates were treated similarly except they did not
receive pRK-Myc-NIK. The cells were harvested at 24 h and cell
extracts were prepared for the IKK assay as described above.
| |
Results |
|---|
|
|
|---|
Extracted GrTPs Inhibited the Phosphorylation of I
B.
We
initially examined the effect of TNF
on IKK activity in IEC-6 cells
by monitoring the in vitro phosphorylation of an I
B
-GST fusion
protein. At baseline (time 0), there was detectable IKK-like activity
in cytosolic extracts (Fig. 1A). After
treatment with TNF
(500 U/ml), cytosolic IKK activity increased
within 5 min and remained elevated for at least 30 min (Fig. 1A). This
was associated with increased nuclear NF-
B binding activity that peaked 30 min after stimulation (Fig. 1B). Supershift experiments confirmed that the observed NF-
B band was the active heterodimer, p65/p50 (data not shown).
|
-mediated
phosphorylation of I
B. The cells were pretreated with GrTP (0-0.4 mg/ml) for 2 h and then exposed to TNF
(500 U/ml) for 5 min. The cytosolic extracts were then assessed for their ability to phosphorylate I
B
-GST. GrTP decreased TNF
-induced I
B
phosphorylation in a dose-dependent fashion (Fig.
2A). This corresponded to a similar
reduction in nuclear NF-
B binding activity (Fig. 2B). These data
clearly showed that the GrTP extract inhibited the phosphorylation of
I
B
resulting in a reduction in NF-
B activation
|
The Effects of the Various Green Tea Polyphenols on I
B
Phosphorylation.
We next examined the various green tea
polyphenols (EGCG, EGC, EC, ECG) to determine whether differences in
efficacy exist. EGCG has been shown to affect the activity of several
enzymes (Nakane and Ono, 1990
; Stoner and Mukhtar, 1995
; Aucamp et al., 1997
). Therefore, we initially examined EGCG. IEC-6 cells were pretreated with EGCG (0-200 µM) for 2 h followed by stimulation with TNF
(500 U/ml) for 5 min. The cytosolic extracts were assessed for their ability to phosphorylate I
B
. EGCG decreased I
B
phosphorylation in a dose-dependent fashion (Fig.
3A). We then compared EGCG to the other
green tea polyphenols (EGC, ECG, EC). The cells were pretreated with
equimolar concentrations (200 µM) of EGC, ECG, EC, or EGCG. EGCG
reduced the phosphorylation of I
B
to a much greater extent than
the other polyphenols. The other polyphenols had little or no effects
at the concentration studied. These studies suggested that EGCG
primarily was responsible for the observed inhibition of I
B
phosphorylation. We then investigated whether this also was reflected
in differences in downstream events. We compared EGCG to EGC, because
they differ only in that EGCG has a gallate group. We examined their
ability to inhibit TNF
-mediated cytokine production. The cytokine
studied was CINC, a NF-
B-responsive chemokine. IEC-6 cells were
pretreated with EGCG or EGC (0-100 µM) for 2 h followed by
stimulation with TNF
(500 U/ml). The supernatants were collected at
18 h and assayed for CINC (Fig. 4).
EGCG decreased CINC release to a much greater extent than EGC. These
results were consistent with our prior observations.
|
|
EGCG Inhibited TNF
-Induced IKK Activity in a Cell-Free
System.
Our data clearly showed that EGCG inhibited TNF
-induced
phosphorylation of I
B
. However, these experiments did not
determine whether EGCG blocks the activation of IKK or inhibits the
activity of IKK. Therefore, we focused on the effects of EGCG on
activated IKK. The source of activated IKK was cytosolic extracts from
IEC-6 cells stimulated for 5 min with TNF
(500 U/ml). We incubated the TNF
-stimulated cytosolic extracts with EGCG (0-200 µM) on ice
for 20 min and detected changes in IKK activity. EGCG decreased IKK
activity in a dose-response fashion. Fifty-percent inhibition was
calculated to be 18 µM (IC50 = 18 µM)
(Figure. 5). We next examined whether or
not any of the other green tea polyphenols inhibited activated IKK. The
TNF
-stimulated cytosolic extracts were incubated with 200 µM EGCG,
EGC, ECG, EC, or catechin (backbone of the polyphenols) and IKK
activity was detected. Other than EGCG, only ECG inhibited IKK activity
and was about 5-fold less effective (Fig.
6, A and B). EGCG and ECG both contain
gallate groups. Therefore, we examined gallic acid (200 µM) and its
methyl ester (200 µM) and found that they were very weak inhibitors
(20-30% inhibition versus 95% inhibition; Fig. 6, A and B). These
data showed that EGCG and (to a much lesser extent) ECG inhibited IKK activity. Importantly, the gallate group was functionally necessary for
inhibition of IKK activity, and the presence of the catechin structure
dramatically enhanced this effect.
|
|
EGCG, a Specific Inhibitor of IKK.
There are several molecules
that inhibit NF-
B activation by blocking I
B-
phosphorylation
(Beauparlant and Hiscott, 1996
). Among these are antioxidants, such as
PDTC and NAC. NAC has been shown to inhibit IKK activation in
endothelial cells (Spiecker et al., 1998
). We examined whether
antioxidants could inhibit activated IKK in vitro. The experiments were
performed as described above. TNF
-stimulated cytosolic extracts of
IEC-6 cells were incubated with various antioxidants [PDTC,
-tocopheryl acetate (vitamin E), NAC, butylated
hydroxytolvene, dimethyl sulfoxide] and IKK activity was
detected. As shown in Fig. 7, none of
these antioxidants inhibited IKK activity. These results suggested that the inhibitory effect of EGCG was not mediated by an antioxidant mechanism, but rather was structure-related. As expected,
N-tosyl-L-phenylalanine chloromethylketone (TPCK), a serine protease inhibitor that blocks I
B degradation downstream (Zandi et al., 1998
), did not
inhibit IKK activity (Fig. 7).
|
B
protein was used as the substrate for
detecting IKK activity. IKK phosphorylates I
B
at Ser-32 and
Ser-36. I
B
has other potential phosphorylation sites that could
be phosphorylated by other kinases activated in response to TNF
stimulation. To date, only ultraviolet radiation and anoxia are known
to phosphorylate I
B without activation of IKK (Karin, 1999
B activator (Regnier et al.,
1997
experiments,
EGCG decreased IKK activity in the NIK transiently transfected cells in
a dose-dependent fashion (Fig. 8). These
data confirmed that EGCG inhibited IKK activity and that our findings
were not related to changes in nonspecific kinase activity.
|
| |
Discussion |
|---|
|
|
|---|
We have identified two structurally related compounds, EGCG and
ECG that inhibit IKK phosphorylation of I
B
. These two compounds, derived from green tea, are catechins with gallate groups. The gallate
group is essential for this inhibitory effect, because polyphenols
lacking the gallate group did not inhibit IKK activity. Gallic acid and
its methyl ester are very weak inhibitors in a cell-free system. The
catechin backbone confers greater efficacy. Of the two, EGCG was much
more potent than ECG. EGCG differs only in that it contains one more
hydroxyl group. Importantly, this phenomenon was not related to an
antioxidant effect, because antioxidants and polyphenols lacking the
gallate group did not inhibit IKK activity. Our data clearly shows that
EGCG inhibits IKK phosphorylation of I
B
. This may occur as a
direct effect on IKK or by interfering with the interaction of IKK with
I
B.
The phosphorylation of I
B is a key regulatory step that dictates
NF-
B activation. In nearly all instances, IKK controls I
B
phosphorylation (Karin, 1999
). IKK is a large 500- to 900-kDa protein
complex with three subunits. Two of the subunits, IKK
and IKK
,
are serine kinases (Mercurio et al., 1997
; Regnier et al., 1997
;
Woronicz et al., 1997
; Zandi et al., 1997
). A third subunit, IKK
,
interacts preferentially with IKK
and seems necessary for activation
(Rothwarf et al., 1998
). IKK directly phosphorylates two serine
residues at the NH2-termini of I
B
(Ser-32,
Ser-36) and I
B
(Ser-19, Ser-23) (Salah et al., 1995
). This
phosphorylation event triggers the polyubiquitination of I
B and
subsequent degradation by the 26S proteasome (Zandi et al., 1998
). Of
the three subunits, the phosphorylation of IKK
is necessary for IKK
activation and IKK
seems responsible for phosphorylation of I
B
(Delhase et al., 1999
).
EGCG and ECG also inhibit the activity of other enzymes. For instance,
EGCG and ECG reduced the activities of reverse transcriptase and
cellular DNA and RNA polymerases (Nakane and Ono, 1990
). EGCG competitively inhibited xanthine oxidase, although the remaining polyphenols were less potent and showed a mixed pattern of inhibition (Aucamp et al., 1997
). EGCG also inhibited epidermal growth
factor-stimulated tyrosine phosphorylation of the epidermal growth
factor receptor (Liang et al., 1997
). Using molecular modeling
techniques, EGCG should bind to urokinase and interfere with the
ability of urokinase to recognize its substrate (Jankun et al., 1997
).
These studies suggest that EGCG may have other cellular targets that
could alter function at various levels.
A number of antioxidants, such as PDTC, NAC, and vitamin E, can
suppress NF-
B activation (Suzuki and Packer, 1993
; Beauparlant and
Hiscott, 1996
), and NAC was reported to inhibit activation of IKK
(Spiecker et al., 1998
). Our findings indicated that these antioxidants
did not affect the activity of IKK. These data support the premise that
antioxidants block activation of IKK and that reactive oxygen species
play an intermediary role upstream to IKK. The green tea polyphenols
are potent antioxidants; as such, they may also inhibit activation of
IKK. Therefore, EGCG may block NF-
B activation at two potential
steps in the pathway. First, as an antioxidant, it may inhibit
signaling events upstream to IKK that result in decreased IKK
activation. Secondly, its unique structure inhibits IKK activity. Both
mechanisms would lead to inhibition of NF-
B activation.
We chose to study IEC-6 cells because of our research focus in
inflammatory bowel disease, because these cells are potent producers of
proinflammatory cytokines/chemokines and because the intestinal
epithelium is an initial target for polyphenol therapeutic
intervention. Thus, the intestinal epithelium may derive
antiinflammatory effect from green tea polyphenols even if the
polyphenols have limited systemic absorption. The activation of NF-
B
may play a critical role in the development and perpetuation of many
inflammatory disorders such as inflammatory bowel disease and
rheumatoid arthritis (Barnes and Karin, 1997
; Baeuerle and Baichwal,
1997
). Indeed, several groups have reported increased intestinal NF-
B activation in patients with inflammatory bowel disease and in
animal models of inflammatory bowel disease. NF-
B, therefore, is a
potential target for anti-inflammatory therapies. Many of the currently
accepted medical therapies for these diseases inhibit NF-
B (e.g.,
glucocorticoids, sulfasalazine). The identification of new more
selective inhibitors of NF-
B may lead to more effective treatment of
inflammatory disorders. IKK represents a key control point for NF-
B
activation and may be a suitable target for modulating NF-
B-mediated
cellular responses. The identification of EGCG as an inhibitor of IKK
should provide insight into the IKK complex and potentially lead to the
development of new IKK inhibitors that are more potent and hopefully
more selective. Our findings also suggest that green tea polyphenols
have a potential therapeutic utility in the treatment of inflammatory diseases.
| |
Acknowledgment |
|---|
We thank K. Westberry and D. Schweder for their technical assistance.
| |
Footnotes |
|---|
Received May 10, 2001; Accepted May 21, 2001
This work was supported by National Institutes of Health Grants KO8-DK02401-01A, MO1-RR02602, IPO1-NS31220-01A1, and RO1-AA010762 and by the Veterans Administration.
Craig J. McClain, MD, Professor of Medicine, Digestive Diseases and Nutrition, University of Louisville Medicine Center, Ambulatory Care Building, Louisville, KY 40292. E-mail: craig.mcclain{at}louisville.edu
| |
Abbreviations |
|---|
EC, epicatechin;
EGC, (
)-epigallocatechin;
ECG, (
)-epicatechin-3-gallate;
EGCG, (
)-epigallocatechin-3-gallate;
TNF, tumor necrosis factor;
LPS, lipopolysaccharide;
NF-
B, nuclear
factor-
B;
IKK, I
B kinase;
PDTC, pyrrolidinedithiocarbamate;
NAC, N-acetyl cysteine;
GrTP, green tea polyphenols;
GST, glutathione S-transferase;
EMSA, electrophoretic
mobility shift assay;
CINC, cytokine-induced neutrophil
chemoattractant;
NIK, NF-
B-inducing kinase.
| |
References |
|---|
|
|
|---|
B in cancer cells versus normal cells.
Arch Biochem Biophysics
376:
338-346[Medline].
B and I
B proteins: new discoveries and insights.
Annu Rev Immunol
14:
649-681[Medline].
B: A pivotal transcription factor in chronic inflammatory diseases.
N Engl J Med
336:
1066-1071
B as a frequent target for immunosuppressive and anti-inflammatory molecules.
Adv Immunol
65:
111-137[Medline].
B/Rel proteins and cytokine synthesis.
Cytokine Growth Factor Rev
7:
175-190[Medline].
B kinase (IKK) and NF-
B activation.
J Biol Chem
274:
27339-27342
)-epigallocatechin gallate in human A431 epidermoid carcinoma cells.
J Cell Biochem
67:
55-65[Medline].
)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-
B.
Mol Pharmacol
52:
465-472
B-inducing kinase action.
Mol Cell Biol
18:
5899-5907
B activity by theaflavin-3,3'-Digallate from black tea and other polyphenols through down-regulation of I
B kinase activity in macrophages.
Biochem Pharmacol
59:
357-367[Medline].
B kinase.
Cell
90:
373-383[Medline].
)-epigallocatechin gallate with (
)-epicatechin, sulindac, or tamoxifen on cancer prevention activity in the human lung cancer cell line PC-9.
Cancer Res
59:
44-47
production and lethality in a murine model.
J Nutr
128:
2334-2340
B kinase-
.
Nature (Lond)
396:
77-80[Medline].This article has been cited by other articles:
![]() |
J. Qin, H.-G. Chen, Q. Yan, M. Deng, J. Liu, S. Doerge, W. Ma, Z. Dong, and D. Wan-Cheng Li Protein Phosphatase-2A Is a Target of Epigallocatechin-3-Gallate and Modulates p53-Bak Apoptotic Pathway Cancer Res., June 1, 2008; 68(11): 4150 - 4162. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Issa, S. R. Volate, S. J. Muga, D. Nitcheva, T. Smith, and M. J. Wargovich Green tea selectively targets initial stages of intestinal carcinogenesis in the AOM-ApcMin mouse model Carcinogenesis, September 1, 2007; 28(9): 1978 - 1984. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ishida, C. Kohda, Y. Yanagawa, H. Miyaoka, and T. Shimamura Epigallocatechin gallate suppresses expression of receptor activator of NF-{kappa}B ligand (RANKL) in Staphylococcus aureus infection in osteoblast-like NRG cells J. Med. Microbiol., August 1, 2007; 56(8): 1042 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. KUNDU and Y.-J. SURH Epigallocatechin Gallate Inhibits Phorbol Ester-Induced Activation of NF-{kappa}B and CREB in Mouse Skin: Role of p38 MAPK Ann. N.Y. Acad. Sci., January 1, 2007; 1095(1): 504 - 512. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.M. Payne, C. Weber, C. Crowley-Skillicorn, K. Dvorak, H. Bernstein, C. Bernstein, H. Holubec, B. Dvorakova, and H. Garewal Deoxycholate induces mitochondrial oxidative stress and activates NF-{kappa}B through multiple mechanisms in HCT-116 colon epithelial cells Carcinogenesis, January 1, 2007; 28(1): 215 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Sartippour, R. Pietras, D. C. Marquez-Garban, H.-W. Chen, D. Heber, S. M. Henning, G. Sartippour, L. Zhang, M. Lu, O. Weinberg, et al. The combination of green tea and tamoxifen is effective against breast cancer Carcinogenesis, December 1, 2006; 27(12): 2424 - 2433. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wen and T. Walle Methylated Flavonoids Have Greatly Improved Intestinal Absorption and Metabolic Stability Drug Metab. Dispos., October 1, 2006; 34(10): 1786 - 1792. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Guichard, E. Pedruzzi, M. Fay, J.-C. Marie, F. Braut-Boucher, F. Daniel, A. Grodet, M.-A. Gougerot-Pocidalo, E. Chastre, L. Kotelevets, et al. Dihydroxyphenylethanol induces apoptosis by activating serine/threonine protein phosphatase PP2A and promotes the endoplasmic reticulum stress response in human colon carcinoma cells Carcinogenesis, September 1, 2006; 27(9): 1812 - 1827. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Girvan, Y. Teng, L. K. Casson, S. D. Thomas, S. Juliger, M. W. Ball, J. B. Klein, W. M. Pierce Jr., S. S. Barve, and P. J. Bates AGRO100 inhibits activation of nuclear factor-{kappa}B (NF-{kappa}B) by forming a complex with NF-{kappa}B essential modulator (NEMO) and nucleolin. Mol. Cancer Ther., July 1, 2006; 5(7): 1790 - 1799. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Lambert, M.-J. Lee, L. Diamond, J. Ju, J. Hong, M. Bose, H. L. Newmark, and C. S. Yang DOSE-DEPENDENT LEVELS OF EPIGALLOCATECHIN-3-GALLATE IN HUMAN COLON CANCER CELLS AND MOUSE PLASMA AND TISSUES Drug Metab. Dispos., January 1, 2006; 34(1): 8 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakazato, K. Ito, Y. Ikeda, and M. Kizaki Green Tea Component, Catechin, Induces Apoptosis of Human Malignant B Cells via Production of Reactive Oxygen Species Clin. Cancer Res., August 15, 2005; 11(16): 6040 - 6049. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Bitler, T. M. Viale, B. Damaj, and R. Crea Hydrolyzed Olive Vegetation Water in Mice Has Anti-Inflammatory Activity J. Nutr., June 1, 2005; 135(6): 1475 - 1479. [Abstract] [Full Text] [PDF] |
||||
|
|